Daily non-political popular news in brief.

Substance in tree bark could lead to new lung-cancer treatment

08-14-2007 · UT Southwestern Medical Center

UT Southwestern Medical Center researchers have discovered a treatment that counteracts the effects of cocaine on the human cardiovascular system, including lowering the elevated heart rate and blood pressure often found in cocaine users.

Keywords: substance, tree, bark, lead, lung-cancer, treatment, lung, cancer

« Previous | Next »

Similar news on "Substance in tree bark could lead to new lung-cancer treatment":

Substance in tree bark could lead to new lung-cancer treatment
06-25-2007 · UT Southwestern Medical Center
Researchers at UT Southwestern Medical Center have determined how a substance derived from the bark of the South American lapacho tree kills certain kinds of cancer cells, findings that also suggest a novel treatment for the most common type of lung cancer.
Similar news · Read more »
Study shows no survival benefit for CT screening for lung cancer
03-06-2007 · EurekAlert!
The first report of an international study looking at computed tomography (CT) to screen current or former smokers for lung cancer found that screening did not reduce deaths from lung cancer. Although CT screening found nearly three times as many lung cancers as predicted, the researchers found that early detection and treatment did not lead to a corresponding decrease in advanced lung cancers or a reduction in deaths from lung cancer.
Similar news · Read more »
Sea creature's toxin could lead to promising cancer treatment
02-05-2007 · UT Southwestern Medical Center
A toxin derived from a reclusive sea creature resembling a translucent doughnut has inspired UT Southwestern Medical Center researchers to develop a related compound that shows promise as a cancer treatment.
Similar news · Read more »
GSK announces launch of largest ever Phase III trial in lung cancer treatment
06-05-2007 · EurekAlert!
GlaxoSmithKline today announced final results of a Phase II clinical trial of its investigational Antigen-Specific Cancer Immunotherapeutic MAGE-A3 in non small cell lung cancer. Final trial analysis showed a 27 percent reduction in the relative risk of cancer recurrence following surgery, compared to placebo. GSK also announced today the launch of a Phase III efficacy and safety trial for this novel cancer immunotherapy; the largest clinical trial ever conducted in lung cancer treatment.
Similar news · Read more »
Ancient mechanism for coping with stresses also gives cancer a boost
09-20-2007 · EurekAlert!
An ancient mechanism for coping with environmental stresses, including heat and toxic exposures, also helps cancerous tumors survive, reveals a new report in the Sept. 21, 2007, issue of Cell, a publication of Cell Press. The findings could lead to a new way to treat cancer and may also have implications for the treatment of neurodegenerative and other diseases, according to the researchers.
Similar news · Read more »
Smoking does not lead to more aggressive or advanced breast cancers
10-28-2007 · EurekAlert!
Smoking cigarettes is associated with an increased risk of cancers of the lung, head and neck, esophagus, bladder and many others and also affects response to anti-cancer treatments. But smoking does not result in more advanced stage diagnoses or aggressive breast cancers at the time of diagnosis. That is the result of an analysis of 35 years of data for more than 6,000 patients.
Similar news · Read more »
MIT: Remote-control nanoparticles deliver drugs directly into tumors
11-16-2007 · EurekAlert!
MIT scientists have devised remotely controlled nanoparticles that, when pulsed with an electromagnetic field, release drugs to attack tumors. The innovation, reported in the Nov. 15 online issue of Advanced Materials, could lead to the improved diagnosis and targeted treatment of cancer.
Similar news · Read more »
UAB research could improve the prognosis and treatment of lung cancer
01-07-2008 · EurekAlert!
A group of scientists at the Universitat Autònoma de Barcelona, has published research on an enzyme that is detected in large quantities only in lung cancers. This enzyme can appear even when the cancer has not yet developed. Thus this molecule would serve as a good marker in the diagnosis and prognosis of the disease. The research is of great interest for potential future therapeutical applications as well.
Similar news · Read more »
Herbal extract extends life for heart failure patients
03-27-2007 · EurekAlert!
An herbal medicinal substance, Crataegus Extract WS1442, safely extends the lives of congestive heart failure patients already receiving pharmacological treatment for the disease, according to a study presented today at the American College of Cardiology’s 56th Annual Scientific Session. Crataegus Extract WS1442 is an extract of leaves of the Crataegus tree, and is a natural antioxidant. The herb is currently approved for use in some European countries to treat early congestive heart failure.
Similar news · Read more »
Ireland Cancer Center researchers advance lung cancer treatment
04-23-2007 · EurekAlert!
Researchers at the Ireland Cancer Center of University Hospitals Case Medical Center have developed methods for treating lung cancer cells that have become resistant to new anti-cancer agents, such as Tarceva (erlotinib). Using a new second-generation of Tarceva-like medications, researchers can overcome the drug resistance, and such drugs are now in development including in clinical trials at the Ireland Cancer Center.
Similar news · Read more »